Showing results (271-280 of 308) with videos related to
Sort By:
Pageof 31
Inflammatory Bowel Diseases|March 11, 2021
Monocytosis Is a Biomarker of Severity in Inflammatory Bowel Disease: Analysis of a 6-Year Prospective Natural History RegistryAlyce Anderson, Cynthia Cherfane, Benjamin Click, et al.Clinical and Translational Gastroenterology|July 15, 2016
Group-Based Trajectory Modeling of Healthcare Financial Charges in Inflammatory Bowel Disease: A Comprehensive PhenotypeJianfei Jiang, Benjamin Click, Alyce M Anderson, et al.Digestive Diseases and Sciences|September 14, 2016
Development of an Inflammatory Bowel Disease Research Registry Derived from Observational Electronic Health Record Data for Comprehensive Clinical PhenotypingAlyce J M Anderson, Benjamin Click, Claudia Ramos-Rivers, et al.Inflammatory Bowel Diseases|July 22, 2015
Silent Crohn's Disease: Asymptomatic Patients with Elevated C-reactive Protein Are at Risk for Subsequent HospitalizationBenjamin Click, Eric J Vargas, Alyce M Anderson, et al.Journal of Clinical Gastroenterology|August 3, 2022
Development and Validation of a Novel 1-year Mortality Risk Score That Includes the Use of Antithrombotic in Patients With Overt Gastrointestinal BleedingTarek Nammour, Lara El Jamal, Mohammad N Hosni, et al.Inflammatory Bowel Diseases|October 19, 2016
Silent Crohn's Disease Predicts Increased Bowel Damage During Multiyear Follow-up: The Consequences of Under-reporting Active InflammationAbhik Bhattacharya, Bhavana B Rao, Ioannis E Koutroubakis, et al.Gastroenterology|January 13, 2010
Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitisWilliam J Sandborn, Joshua Korzenik, Bret Lashner, et al.Gastro Hep Advances|April 20, 2026
Oral Vancomycin Is an Effective Therapy in Adult Patients With Inflammatory Bowel Disease and Primary Sclerosing CholangitisSiri A Urquhart, Prajith Raj Ramesh, Sunanda V Kane, et al.Crohn'S & Colitis 360|February 13, 2023
Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic ColitisThomas W Fredrick, Guilherme P Ramos, Manuel B Braga Neto, et al.The American Journal of Gastroenterology|November 8, 2017
Peripheral Eosinophilia in Patients With Inflammatory Bowel Disease Defines an Aggressive Disease PhenotypeBenjamin Click, Alyce M Anderson, Ioannis E Koutroubakis, et al.Pageof 31